⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine EU May 6, 2026

NexoBrid

📷 EU Safety Watch placeholder
NexoBrid
📷 EU Safety Watch placeholder
INN
concentrate of proteolytic enzymes enriched in bromelain
Area
Debridement
Alternatives
No
⚠️
Shortage ongoing
concentrate of proteolytic enzymes enriched in bromelain is currently in short supply in EU.
📈 Timeline
69 days active so far
May 20, 2026 July 27, 2026

What is this? NexoBrid is a medicine used to clean burns on the skin. It helps remove dead tissue so new skin can grow.

What's happening? There is a shortage of NexoBrid in the EU. Hospitals and pharmacies may not have enough supply.

Does this affect me? If you or someone in your care has a severe burn, this shortage could affect treatment.

What should I do? Ask your doctor or pharmacist about other burn care options. Do not change your treatment without their advice.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
NexoBrid
Agency-published detail

INN: concentrate of proteolytic enzymes enriched in bromelain · Area: Debridement · Alternatives: No

First published
May 6, 2026
Last refreshed by us
1 month ago
Severity (as classified)
Medium
Official source
http://www.ema.europa.eu/en/medicines/human/shortages/nexobrid

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Medium EU 2 months ago

NexoBrid

INN: concentrate of proteolytic enzymes enriched in bromelain · Area: Debridement · Alternatives: No

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
NexoBrid. INN: concentrate of proteolytic enzymes enriched in bromelain · Area: Debridement · Alternatives: No
▸ When was this alert issued?
This alert was issued on May 6, 2026 by EMA (European Medicines Agency).
▸ Which countries are affected?
The alert applies to the entire EU.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.